Provided by Tiger Trade Technology Pte. Ltd.

Bluejay Diagnostics Inc

1.92
-0.0699-3.51%
Volume:4.76M
Turnover:10.07M
Market Cap:1.36M
PE:-0.01
High:2.26
Open:1.99
Low:1.92
Close:1.99
52wk High:40.80
52wk Low:1.86
Shares:708.53K
Float Shares:572.50K
Volume Ratio:25.04
T/O Rate:830.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-134.4192
EPS(LYR):-456.7450
ROE:-126.20%
ROA:-65.84%
PB:0.37
PE(LYR):0.00

Loading ...

Bluejay Diagnostics Says All Prefunded Warrants Have Been Exercised

Reuters
·
Yesterday

Bluejay Advances SYMON II Sepsis Study and Manufacturing

TIPRANKS
·
Feb 18

Bluejay Diagnostics Enrolls 545 Patients in SYMON II Clinical Study

Reuters
·
Feb 17

Bluejay Diagnostics Successfully Enrolls 545 Patients in Symon™ Ii Study and Advances Manufacturing Readiness Into 2026

THOMSON REUTERS
·
Feb 17

Bluejay Diagnostics Inc trading halted, news pending

TIPRANKS
·
Jan 29

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

Reuters
·
Jan 29

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

GlobeNewswire
·
Jan 27

Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics

Reuters
·
Jan 26

Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

GlobeNewswire
·
Dec 29, 2025

Bluejay Diagnostics Reports Q3 Results and Updates

TIPRANKS
·
Nov 11, 2025

Bluejay Diagnostics provides Q3 corporate update

TIPRANKS
·
Nov 10, 2025

Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships

GlobeNewswire
·
Nov 10, 2025

Bluejay Diagnostics Advances Sepsis Study with IL-6 Monitoring

TIPRANKS
·
Oct 28, 2025

Bluejay Diagnostics files to sell 6.93M shares of common stock for holders

TIPRANKS
·
Oct 24, 2025

BRIEF-Bluejay Diagnostics Inc - Enters Into Securities Purchase Agreement On Oct 9 - SEC Filing

Reuters
·
Oct 14, 2025

Bluejay Diagnostics Raises $4M in Private Placement

TIPRANKS
·
Oct 14, 2025

Bluejay Diagnostics Inc - Private Placement Closed on October 10, 2025 - SEC Filing

THOMSON REUTERS
·
Oct 14, 2025

Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Reuters
·
Oct 14, 2025

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

GlobeNewswire
·
Oct 11, 2025

Press Release: Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Dow Jones
·
Oct 10, 2025